老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lineage Cell Therapeutics Inc

1.01
-0.0100-0.98%
盤前：1.020.0072+0.71%05:13 EDT
成交量：91.34萬
成交額：92.49萬
市值：2.55億
市盈率：-5.44
高：1.03
開：1.02
低：1.00
收：1.02
52周最高：2.09
52周最低：1.00
股本：2.53億
流通股本：1.91億
量比：0.86
換手率：0.48%
股息：- -
股息率：- -
每股收益(TTM):-0.1855
每股收益(LYR):-0.2761
淨資產收益率：-60.06%
總資產收益率：-17.04%
市淨率：4.19
市盈率(LYR):-3.66

資料載入中...

總覽公司新聞公告
2020/05/06

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/28

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/27

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/12

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/13

重要事件披露

Current report, items 7.01 and 9.01
2020/01/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/12

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/12

重要事件披露

Current report, items 2.02 and 9.01
2019/10/18

重要事件披露

Current report, item 8.01
2019/10/15

重要事件披露

Current report, items 8.01 and 9.01
2019/09/19

重要事件披露

Current report, items 8.01 and 9.01
2019/09/13

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/15

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

重要事件披露

Current report, items 5.03, 8.01, and 9.01
2019/08/08

員工持股計劃

Securities to be offered to employees in employee benefit plans
更多